a KA (Kaletra 200 mg / 50 mg)
Generic Name: lopinavir/ritonavir
Pill with imprint a KA is Yellow, Elliptical / Oval and has been identified as Kaletra 200 mg / 50 mg. It is supplied by Abbott Laboratories.
Kaletra is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Kaletra 200 mg / 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for a KA




Kaletra
- Generic Name
- lopinavir/ritonavir
- Imprint
- a KA
- Strength
- 200 mg / 50 mg
- Color
- Yellow
- Size
- 19.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Abbott Laboratories
- Inactive Ingredients
-
copovidone, sorbitan monolaurate, sodium stearyl fumarate, titanium dioxide, polyethylene glycol 400, magnesium silicate, polyethylene glycol 3350, ferric oxide yellow, polysorbate 80, hypromelloses, hydroxypropyl cellulose (type h), silicon dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00074-6799 | Abbott Laboratories |
54569-5752 | A-S Medication Solutions, LLC (repackager) |
54868-5566 | Physicians Total Care Inc. (repackager) |
55289-0947 | PDRX Pharmaceuticals Inc. (repackager) |
35356-0112 | Lake Erie Medical and Surgical Supply (repackager) |
68071-0748 | Nucare Pharmaceuticals Inc. (repackager) |
Related Images for "a KA"
More about Kaletra (lopinavir / ritonavir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Generic Availability
- Drug class: protease inhibitors
- FDA Alerts (4)
Consumer resources
- Kaletra
- Kaletra (Advanced Reading)
- Kaletra (Lopinavir and Ritonavir Oral Solution)
- Kaletra (Lopinavir and Ritonavir Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.